| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,222 |
2,888 |
$185K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,009 |
1,863 |
$144K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,050 |
965 |
$89K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
772 |
711 |
$31K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
262 |
237 |
$28K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
311 |
273 |
$23K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
338 |
299 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
976 |
926 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
318 |
291 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
730 |
337 |
$9K |
| 87428 |
|
19 |
16 |
$519.84 |
| 99000 |
|
761 |
704 |
$294.32 |
| 81003 |
|
58 |
54 |
$120.12 |